Outcomes of poor peripheral blood stem cell mobilizers with multiple myeloma at the first mobilization: A multicenter retrospective study in Japan

Autologous stem cell transplantation (ASCT) remains an important therapeutic strategy for multiple myeloma; however, a proportion of patients fail to mobilize a sufficient number of peripheral blood stem cells (PBSCs) to proceed to ASCT. In the present study, we aimed to clarify the characteristics...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyamoto‐Nagai, Yurie, Mimura, Naoya, Tsukada, Nobuhiro, Aotsuka, Nobuyuki, Ri, Masaki, Katsuoka, Yuna, Wakayama, Toshio, Suzuki, Rikio, Harazaki, Yoriko, Matsumoto, Morio, Kumagai, Kyoya, Miyake, Takaaki, Ozaki, Shuji, Shono, Katsuhiro, Tanaka, Hiroaki, Shimura, Arika, Kuroda, Yoshiaki, Sunami, Kazutaka, Suzuki, Kazuhito, Yamashita, Takeshi, Shimizu, Kazuyuki, Murakami, Hirokazu, Abe, Masahiro, Nakaseko, Chiaki, Sakaida, Emiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Haematologic Malignancy ‐ Plasma Cell
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422024/
https://www.ncbi.nlm.nih.gov/pubmed/36051061
http://dx.doi.org/10.1002/jha2.534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422024/
https://www.ncbi.nlm.nih.gov/pubmed/36051061
http://dx.doi.org/10.1002/jha2.534

Ejemplares similares